e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

20th September 2019 by Louise Hudman

e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.

What is ertugliflozin?

It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.

It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.

Read for free

Sign up to access everything.

Free trial

Login

Already a member? Login to view this content.

Login

Related content

"Love LocumDeck. Invoice sent for this month. Super quick and easy once set-up. Form all calculated - lovely! "

Dr Kate Little

See the full list of features within our NASGP membership plans

Membership